RemoteClinic up to 2.0 /staff/edit.php Last Name cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.8 | $0-$5k | 0.00 |
Summary
A vulnerability has been found in RemoteClinic up to 2.0 and classified as problematic. This issue affects some unknown processing of the file /staff/edit.php. The manipulation of the argument Last Name leads to cross site scripting. This vulnerability is listed as CVE-2025-9773. The attack may be initiated remotely. In addition, an exploit is available.
Details
A vulnerability was found in RemoteClinic up to 2.0. It has been rated as problematic. This issue affects an unknown part of the file /staff/edit.php. The manipulation of the argument Last Name with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity.
The advisory is shared at github.com. The identification of this vulnerability is CVE-2025-9773. The exploitation is known to be easy. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Technical details as well as a public exploit are known. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
The exploit is available at github.com. It is declared as proof-of-concept. By approaching the search of inurl:staff/edit.php it is possible to find vulnerable targets with Google Hacking.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-26335). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.9VulDB Meta Temp Score: 4.8
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔒
CNA Base Score: 4.3
CNA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
Google Hack: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
08/31/2025 Advisory disclosed08/31/2025 VulDB entry created
09/05/2025 VulDB entry last update
Sources
Advisory: github.comStatus: Not defined
CVE: CVE-2025-9773 (🔒)
GCVE (CVE): GCVE-0-2025-9773
GCVE (VulDB): GCVE-100-322073
EUVD: 🔒
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 08/31/2025 22:03Updated: 09/05/2025 01:16
Changes: 08/31/2025 22:03 (54), 09/01/2025 12:27 (30), 09/01/2025 16:53 (1), 09/05/2025 01:16 (11)
Complete: 🔍
Submitter: 03hice
Cache ID: 216::103
Submit
Accepted
- Submit #640893: github.com Remote Clinic V2.0 Cross Site Scripting (by 03hice)
Duplicate
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.